Mizuho Maintains Outperform on Hologic, Raises Price Target to $90
Portfolio Pulse from Benzinga Newsdesk
Mizuho analyst Anthony Petrone maintains an Outperform rating on Hologic and raises the price target from $85 to $90.
October 04, 2024 | 4:27 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Mizuho analyst Anthony Petrone has maintained an Outperform rating on Hologic and increased the price target from $85 to $90, indicating a positive outlook for the stock.
The increase in the price target from $85 to $90 by Mizuho suggests a positive outlook for Hologic's stock. Maintaining an Outperform rating indicates confidence in the company's performance, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100